September 18, 2019
Graybug Vision kicks off clinical trial in Macular Edema Secondary to Diabetic Macular Edema or Retinal Vein Occlusion
Graybug Vision has kicked off second phase of testing microparticle depot formulation of sunitinib malate for intravitreal (IVT) injection (GB-102) in patients with macular edema (ME) secondary to diabetic ME or retinal vein occlusion (RVO).